Report #2850223

Received Jul 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 75 yrs
State: NV
Recovered: Unknown
Vaccinated: Jul 13, 2025
Onset: Jul 13, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	G22GH	IM / LA

Symptoms (1)

Expired product administered

Symptom narrative

expired vaccine administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 75-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number G22GH, expiry date 01-JUL-2025) for prophylaxis. On 13-JUL-2025, the patient received Arexvy (intramuscular, left arm). On 13-JUL-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: expired vaccine administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 14-JUL-2025 The pharmacist calling on behalf patient stated that they administered a dose of Arexvy to the patient day before reporting and the vaccine expired which led to, expired vaccine used. The reporter stated she did file a report of the incident in VAERS.